ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 216 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.93 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $3,229,000 | -24.6% | 34,640 | -51.9% | 0.01% | -33.3% |
| Q3 2021 | $4,282,000 | -14.0% | 71,964 | -1.6% | 0.01% | -18.2% |
| Q2 2021 | $4,981,000 | +9.4% | 73,130 | +13.0% | 0.01% | 0.0% |
| Q1 2021 | $4,552,000 | -28.6% | 64,737 | -22.0% | 0.01% | -31.2% |
| Q4 2020 | $6,377,000 | +4.3% | 83,006 | +1.5% | 0.02% | -11.1% |
| Q3 2020 | $6,116,000 | +5.9% | 81,809 | -11.5% | 0.02% | 0.0% |
| Q2 2020 | $5,776,000 | +700.0% | 92,446 | +618.1% | 0.02% | +800.0% |
| Q2 2019 | $722,000 | +72100.0% | 12,874 | +67657.9% | 0.00% | – |
| Q2 2018 | $1,000 | – | 19 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 164,300 | $9,633,000 | 4.86% |
| Atika Capital Management LLC | 230,000 | $13,485,000 | 2.65% |
| DAFNA Capital Management LLC | 93,942 | $5,508,000 | 2.07% |
| PFM Health Sciences, LP | 1,828,378 | $107,198,000 | 2.04% |
| Perceptive Advisors | 1,380,171 | $80,919,000 | 1.86% |
| Eversept Partners, LP | 73,501 | $4,309,364 | 1.21% |
| Partner Investment Management, L.P. | 18,159 | $1,065,000 | 1.13% |
| Rhenman & Partners Asset Management AB | 170,000 | $9,967,000 | 1.10% |
| EMERALD ADVISERS, LLC | 425,510 | $24,948,000 | 1.00% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 388,418 | $22,773,000 | 0.90% |